Percutaneous rheolytic thrombectomy of thrombosed autogenous dialysis fistulas: technical results, clinical outcome, and factors influencing patency

Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
Geert MaleuxSam Heye

Abstract

To retrospectively analyze the technical and clinical outcome of percutaneous rheolytic thrombectomy with the use of the AngioJet device in thrombosed autogenous arteriovenous dialysis fistulas. A cohort of 38 consecutive patients (24 men; mean age 70.7 ± 13.8 years) presenting with 59 thrombotic events in 39 autogenous dialysis fistulas were retrospectively analyzed. The AngioJet rheolytic thrombectomy device was used in all cases. Adjunctive therapies, as well as procedure-related complications, were noted. Primary, assisted primary, and secondary patency of the autogenous fistulas was assessed along with factors potentially influencing patency. Initial technical success to recanalize the efferent vein was 100% (n = 59), and a successful postprocedure dialysis session was possible in 97% (n = 57) of cases. Adjunctive procedures included percutaneous thromboaspiration (n = 4, 7%), balloon angioplasty (n = 59, 100%), and stent placement (n = 16, 27%). Complications related to thrombectomy occurred in 3 (5%) procedures (distal arterial embolus). Primary, assisted primary, and secondary patency rates at 12 months were 56.1% (95% CI 42.8% to 75.2%), 61.6% (95% CI 48.6% to 74.7%), and 86.2% (95% CI 74.9% to 97.5%), respectively. Ri...Continue Reading

References

Mar 18, 2000·Kidney International·L Turmel-RodriguesD Blanchard
Mar 7, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Dec 14, 2001·Journal of Vascular and Interventional Radiology : JVIR·L Turmel-RodriguesM Sapoval
Dec 10, 2002·Journal of Vascular and Interventional Radiology : JVIR·Dheeraj K RajanKenneth Sniderman
May 29, 2003·Techniques in Vascular and Interventional Radiology·Luc Turmel-Rodrigues
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Josh B ShatskyScott O Trerotola
Nov 16, 2007·Journal of Vascular and Interventional Radiology : JVIR·Sam HeyeGeert Maleux
Feb 8, 2008·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Stavros K KakkosMartha M Scully
Dec 31, 2008·Cardiovascular and Interventional Radiology·Peter LittlerSteven Powell
Dec 15, 2010·Clinical Radiology·C L BentM B Matson
Apr 19, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Chih-Chung YangChih-Cheng Wu
Aug 7, 2012·The Journal of Vascular Access·Eugene SimoniRobert Lookstein

❮ Previous
Next ❯

Citations

Apr 23, 2016·Journal of Vascular and Interventional Radiology : JVIR·Michael C HsuTimothy W I Clark
Sep 14, 2016·Journal of Vascular and Interventional Radiology : JVIR·Sean R DariushniaUNKNOWN Society of Interventional Radiology Standards of Practice Committee
Jan 14, 2020·The Journal of Vascular Access·Filippo PiacentinoEugenio Annibale Genovese
Jun 14, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maurizio GallieniEvi Nagler
Jan 17, 2020·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Johannes W DrouvenClark J Zeebregts
Jul 20, 2017·Cardiovascular Engineering and Technology·Nicholas InstonR Jones

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

AngioJet
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.